AJCN Cancer Health Disparities Conference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garland, C. F.
Right arrow Articles by Gorham, E. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garland, C. F.
Right arrow Articles by Gorham, E. D.
Agricola
Right arrow Articles by Garland, C. F.
Right arrow Articles by Gorham, E. D.

American Journal of Clinical Nutrition, Vol 54, 193S-201S, Copyright © 1991 by The American Society for Clinical Nutrition, Inc


REVIEW ARTICLES

Can colon cancer incidence and death rates be reduced with calcium and vitamin D?

CF Garland, FC Garland and ED Gorham
Department of Community and Family Medicine, University of California, San Diego, La Jolla 92093-0607.

It was proposed in 1980 that vitamin D and calcium could reduce the risk of colon cancer. This assertion was based on the decreasing gradient of mortality rates from north to south, suggesting a mechanism related to a favorable influence of ultraviolet-induced vitamin D metabolites on metabolism of calcium. A 19-y prospective study of 1954 Chicago men found that a dietary intake of greater than 3.75 micrograms vitamin D/d was associated with a 50% reduction in the incidence of colorectal cancer, whereas an intake of greater than or equal to 1200 mg Ca/d was associated with a 75% reduction. Clinical and laboratory studies further support these findings. A nested case-control study based on serum drawn from a cohort of 25,620 individuals reported that moderately elevated concentrations of 25-hydroxyvitamin D, in the range 65-100 nmol/L, were associated with large reductions (P less than 0.05) in the incidence of colorectal cancer.


This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
J. M Lappe, D. Travers-Gustafson, K M. Davies, R. R Recker, and R. P Heaney
Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial
Am. J. Clinical Nutrition, June 1, 2007; 85(6): 1586 - 1591.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. N. Black and R. Scragg
Relationship Between Serum 25-Hydroxyvitamin D and Pulmonary Function in the Third National Health and Nutrition Examination Survey
Chest, December 1, 2005; 128(6): 3792 - 3798.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. Kallay, G. Bises, E. Bajna, C. Bieglmayer, W. Gerdenitsch, I. Steffan, S. Kato, H.J. Armbrecht, and H. S. Cross
Colon-specific regulation of vitamin D hydroxylases--a possible approach for tumor prevention
Carcinogenesis, September 1, 2005; 26(9): 1581 - 1589.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. R. Holt, N. Arber, B. Halmos, K. Forde, H. Kissileff, K. A. McGlynn, S. F. Moss, K. Fan, K. Yang, and M. Lipkin
Colonic Epithelial Cell Proliferation Decreases with Increasing Levels of Serum 25-Hydroxy Vitamin D
Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 113 - 119.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by The American Society for Nutrition